During the past decade, Novant Health Oncology Specialists conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 24 clinical trials were completed, i.e. on average, 82.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 15 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Novant Health Oncology Specialists" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "Gynecologic Oncology Group" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Novant Health Oncology Specialists" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Novant Health Oncology Specialists" are "Breast Cancer" (4 trials), "Breast Carcinoma" (3 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (3 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (3 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Novant Health Oncology Specialists" in a lesser frequency.

Most popular intervention types in "Novant Health Oncology Specialists" are "Drug" (34 trials), "Other" (24 trials), "Biological" (14 trials), "Procedure" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (13 trials), "Placebo" (9 trials), "Laboratory Biomarker Analysis" (8 trials), "Questionnaire Administration" (8 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Novant Health Oncology Specialists" are 28 trials for "All" genders, 14 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Novant Health Oncology Specialists". undefined are not yet recruiting, 2 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Novant Health Oncology Specialists, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Novant Health Oncology Specialists, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".